Manufacturers Life Insurance Company, The Sangamo Therapeutics, Inc Transaction History

Manufacturers Life Insurance Company, The

$108 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.3 - $0.63 $9,144 - $19,202	-30,480 Reduced 46.01%	35,760 $19,000
Q3 2023 Nov 15, 2023	SELL	$0.58 - $1.47 $183 - $464	-316 Reduced 0.47%	66,240 $39,000
Q2 2023 Aug 11, 2023	BUY	$1.11 - $1.74 $15,958 - $25,015	14,377 Added 27.55%	66,556 $86,000
Q4 2022 Aug 11, 2023	SELL	$2.77 - $5.07 $1.82 Million - $3.33 Million	-657,438 Reduced 92.65%	52,179 $163,000
Q4 2022 Feb 13, 2023	SELL	$2.77 - $5.07 $1.82 Million - $3.33 Million	-657,438 Reduced 92.65%	52,179 $163,000
Q3 2022 Aug 11, 2023	SELL	$4.27 - $6.39 $7,720 - $11,553	-1,808 Reduced 0.25%	709,617 $3.48 Million
Q3 2022 Nov 03, 2022	SELL	$4.27 - $6.39 $7,720 - $11,553	-1,808 Reduced 0.25%	709,617 $3.48 Million
Q2 2022 Aug 11, 2023	BUY	$3.28 - $6.21 $1,892 - $3,583	577 Added 0.08%	711,425 $2.95 Million
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $1,892 - $3,583	577 Added 0.08%	711,425 $2.95 Million
Q1 2022 Aug 11, 2023	BUY	$5.23 - $7.82 $3.44 Million - $5.15 Million	658,669 Added 1262.33%	710,848 $4.13 Million
Q1 2022 May 20, 2022	SELL	$5.23 - $7.82 $63,298 - $94,645	-12,103 Reduced 1.67%	710,848 $4.13 Million
Q4 2021 Feb 16, 2022	SELL	$7.29 - $10.97 $1.53 Million - $2.31 Million	-210,458 Reduced 22.55%	722,951 $5.52 Million
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $35,679 - $47,559	-3,960 Reduced 0.42%	933,409 $8.41 Million
Q2 2021 Aug 12, 2021	BUY	$10.17 - $12.64 $13,210 - $16,419	1,299 Added 0.14%	937,369 $11.2 Million
Q1 2021 May 03, 2021	SELL	$10.88 - $17.05 $153,832 - $241,069	-14,139 Reduced 1.49%	936,070 $11.7 Million
Q4 2020 Feb 12, 2021	BUY	$9.23 - $18.18 $16,909 - $33,305	1,832 Added 0.19%	950,209 $14.8 Million
Q3 2020 Nov 09, 2020	SELL	$9.38 - $12.48 $12,756 - $16,972	-1,360 Reduced 0.14%	948,377 $8.96 Million
Q2 2020 Aug 10, 2020	SELL	$6.21 - $11.83 $31,770 - $60,522	-5,116 Reduced 0.54%	949,737 $8.33 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $23,174 - $40,612	4,589 Added 0.48%	954,853 $6.08 Million
Q4 2019 Feb 14, 2020	BUY	$8.03 - $11.7 $2.71 Million - $3.95 Million	337,607 Added 55.11%	950,264 $7.95 Million
Q3 2019 Nov 12, 2019	BUY	$9.05 - $12.22 $4.9 Million - $6.61 Million	541,300 Added 758.58%	612,657 $5.63 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $37,791 - $56,276	4,319 Added 6.44%	71,357 $769,000
Q1 2019 May 13, 2019	BUY	$7.72 - $12.81 $39,611 - $65,728	5,131 Added 8.29%	67,038 $639,000
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $36,984 - $64,557	-3,889 Reduced 5.91%	61,907 $710,000
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $121,547 - $177,431	-9,314 Reduced 12.4%	65,796 $1.12 Million
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $176,099 - $250,846	12,669 Added 20.29%	75,110 $1.07 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $22,461 - $35,440	-1,345 Reduced 2.11%	62,441 $1.19 Million
Q4 2017 Feb 08, 2018	BUY	$11.6 - $17.35 $9,430 - $14,105	813 Added 1.29%	63,786 $1.05 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $528,973 - $944,595	62,973	62,973 $944,000

Others Institutions Holding SGMO

# of Institutions

111

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

Wasatch Advisors Inc Salt Lake City, UT

19.4M
Shares

$23.9 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

9.6M
Shares

$11.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.85M
Shares

$5.97 Million
0.01% of portfolio
Black Rock Inc. New York, NY

4.7M
Shares

$5.78 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.35M
Shares

$2.9 Million
0.0% of portfolio

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $193M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account